Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat accumulates in the liver, causing inflammation and scarring. Over time, this damage ...

Currently, there is only one FDA-approved treatment available ... “By treating both liver disease and its metabolic causes, semaglutide offers a promising new approach for millions of patients.” ...

semaglutide offers a promising new approach for millions of patients," Sanyal said. Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ... Researchers chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat ...